FULL PAPER
orbit contributions were estimated by using the DKH method im-
plemented in Orca.[47]
evaporator yielded the product as a clear orange oil; yield 2.01 g
(91%). 1H NMR (200 MHz, CDCl3, 25 °C): δ = 8.48–8.42 (m, 3
H, 11-H, 18-H, 25-H), 7.61–7.34 (m, 6 H, 13-H, 14-H, 20-H, 21-
H, 27-H, 28-H), 7.13–6.99 (m, 3 H, 12-H, 19-H, 26-H), 3.85 (br. s,
4 H, 15-H, 22-H), 3.39 (d, 2 H, 5-H, 7-H), 2.92–2.72 (m, 6 H, 2-
H, 3-H, 5-H, 7-H), 1.21 (s, 3 H, 8-H) ppm. {1H}13C NMR
(50.32 MHz, CDCl3, 25 °C): δ = 167.46 (1 C, C-9), 159.99 (2 C, C-
16, C-23), 148.94 (2C, C-18, C-25), 148.33 (1C, C-11), 136.39 (2 C,
C-20, C-27), 136.04 (1 C, C-13), 123.25 (2 C, C-21, C-28), 122.01
(1 C, C-14), 121.02 (2 C, C-19, C-26), 120.92 (1 C, C-12), 67.29 (2
C, C-5, C-7), 66.27 (2 C, C-15, C-22), 59.25 (2 C, C-2, C-3), 46.04
(1 C, C-6), 25.64 (1 C, C-8) ppm. C23H27N5 (373.49): calcd. C
73.96, H 7.29, N 18.75; found C 73.20, H 7.26, N 18.88. HRMS
(ESI): calcd. for C23H27N5 [M + H]+ 374.2339; found 374.2331.
Syntheses: The numbering schemes used for the NMR assignments
of 2, 3 and 4a/b are given in the Supporting Information.
6-Methyl-6-(pyridin-2-yl)-1,4-ditosyl-1,4-diazepane (2): Ethylenedi-
amine-1,2-ditoslylate (15.7 mmol, 5.83 g) and NaOH (36.3 mmol,
1.45 g) were dissolved in H2O (100 mL) and the mixture was heated
to reflux until a clear solution had formed. After addition of a
warm solution of 2-methyl-2-(pyridin-2-yl)propane-1,3-diyl bis(4-
methylbenzenesulfonate) (15.7 mmol, 7.52 g) in toluene (100 mL),
the emulsion was heated to reflux for 2 d. Subsequently, the warm
(not boiling) organic phase was decanted, and the aqueous phase
was washed with warm toluene (100 mL). Removal of toluene from
the combined organic phases left the crude product as an orange
solid, which was dissolved in CHCl3. The insoluble components
were removed by filtration, and the solvent of the filtrate was re-
moved under reduced pressure to give 2 as an orange resinous solid.
The product was used in subsequent syntheses without further pu-
rification; yield 6.80 g (86%). 1H NMR (200 MHz, CDCl3, 25 °C):
6-Methyl-6-(pyridin-2-yl)-1,4-bis[2-(pyridin-2-yl)ethyl]-1,4-di-
azepane (4b): To a solution of 3 (5.8 mmol, 1.10 g) in MeOH
(30 mL) was added acetic acid (14.4 mmol, 0.86 g) and 2-vinylpyr-
idine (28.8 mmol, 3.02 g). The reaction mixture was warmed to
65 °C and stirred for 2 d. The mixture was then cooled to room
temperature, and the volatiles were removed under reduced pres-
sure. The remaining red-brown oil was dissolved in H2O and care-
fully made basic with solid NaOH. Compound 4b was sub-
sequently extracted three times with toluene. The removal of tolu-
ene from the combined organic phases left the crude product as a
red oil, which was purified by repeated extraction with small
amounts of hexane. The solvent was removed in vacuo to give 4b
as a light yellow oil; yield 1.42 g (61%). 1H NMR (200 MHz,
3
δ = 8.54 (dm, JH,H = 4 Hz, 1 H, 11-H), 7.77–7.60 (m, 5 H, 13-H,
3
19-H, 23-H, 29-H, 33-H), 7.52 (d, JH,H = 8 Hz, 1 H, 14-H), 7.30–
2
7.16 (m, 5 H, 12-H, 20-H, 22-H, 30-H, 32-H), 3.77 (d, JH,H
=
14 Hz, 2 H, 5-H, 7-H), 3.61–3.44 (m, 4 H, 2-H, 3-H, 5-H, 7-H),
3.24–3.11 (m, 2 H, 2-H, 3-H), 2.41 (s, 6 H, 24-H, 34-H), 1.56 (s, 3
H, 8-H) ppm. {1H}13C NMR (50.32 MHz, CDCl3, 25 °C): δ =
163.19 (1 C, C-9), 148.26 (1 C, C-11), 143.73 (2 C, C-21, C-31),
137.31 (1 C, C-13), 135.50 (2 C, C-18, C-28), 129.96 (4 C, C-20, C-
22, C-30, C-32), 127.32 (4 C, C-19, C-23, C-29, C-33), 122.13 (1 C,
C-14), 121.35 (1 C, C-12), 58.17 (2 C, C-2, C-3), 51.23 (2 C, C-5,
C-7), 46.10 (1 C, C-6), 23.98 (1 C, C-8), 21.62 (2 C, C-24, C-34)
ppm. HRMS (ESI): calcd. for C25H29N3O4S2 [M + H]+ 500.1672;
found 500.1666.
3
CDCl3, 25 °C): δ = 8.50 (dm, JH,H = 4 Hz, 3 H, 11-H), 7.58–7.46
3
(m, 3 H, 13-H, 21-H, 29-H), 7.36 (d, JH,H = 8 Hz, 1 H, 14-H),
2
7.12–7.04 (m, 5 H, 22-H, 30-H, 12-H, 20-H, 28-H), 3.17 (d, JH,H
= 14 Hz, 2 H, 5-H, 7-H), 2.91 (br. s, 8 H, 2-H, 3-H, 15-H, 23-H),
2.81–2.68 (m, 6 H, 5-H, 7-H, 16-H, 24-H), 1.23 (s, 3 H, 8-H) ppm.
{1H}13C NMR (50.32 MHz, CDCl3, 25 °C): δ = 167.81 (1 C, C-9),
160.94 (2 C, C-17, C-25), 149.34 (2 C, C-19, C-27), 148.35 (1 C, C-
11), 136.24 (2 C, C-21, C-29), 136.02 (1 C, C-13), 123.48 (2 C, C-
22, C-30), 121.29 (1 C, C-14), 121.10 (2 C, C-20, C-28), 120.95 (1
C, C-12), 67.11 (2 C, C-5, C-7), 60.67 (2 C, C-2, C-3), 59.56 (2 C,
C-15, C-23), 45.70 (1 C, C-6), 36.30 (2 C, C-16, C-24), 25.35 (1 C,
C-8) ppm. C25H31N5 (401.55): calcd. C 74.78, H 7.78, N 17.44;
found C 74.73, H 7.92, N 17.29. HRMS (ESI): calcd. for C25H31N5
[M + H]+ 402.2652; found 402.2634.
6-Methyl-6-(pyridin-2-yl)-1,4-diazepane
(3):
Compound
2
(10.0 mmol, 5.00 g) was dissolved in H2SO4 (20 mL). The reaction
mixture was heated to 130 °C for 14 h, after which time a black
suspension had formed. The mixture was cooled to 0 °C and care-
fully basified with saturated aqueous NaOH. The aqueous solution
was extracted three times with CHCl3. The volatiles were then re-
moved from the combined organic phases with a rotary evaporator
to leave a yellow oil. The product was used in subsequent syntheses
without purification; yield 1.59 g (80%). 1H NMR (200 MHz,
3
[Fe(4b)Br]Br (5): A solution of FeBr2 (0.74 mmol, 0.16 mg) in
MeOH (3 mL) was added to a methanolic solution (3 mL) of 4b
(0.78 mmol, 0.31 mg). The solution was left to stir at room tem-
perature overnight before the volume of the solution was reduced
to ca. 1 mL with an oil-pump vacuum. The addition of Et2O
(15 mL) precipitated 5 as a yellow powder. The suspension was
centrifuged, the organic solvent was decanted, and the yellow solid
was washed with Et2O (2ϫ 10 mL) and dried in vacuo; yield 0.39 g
(81%). C25H31Br2FeN5 (617.20): calcd. C 48.65, H 5.06, N 11.35;
found C 49.19, H 5.18, N 11.31. HRMS (ESI): calcd. for
C25H31BrFeN5 [M]+ 536.1107; found 536.1096; calcd. for
C25H31FeN5 [M]2+ 228.5959; found 228.5956.
CDCl3, 25 °C): δ = 8.55 (dm, JH,H = 4 Hz, 1 H, 11-H), 7.63 (td,
4
3
3JH,H = 8, JH,H = 2 Hz, 1 H, 13-H), 7.34 (d, JH,H = 8 Hz, 1 H,
2
14-H), 7.15–7.08 (m, 1 H, 12-H), 3.41 (d, JH,H = 14 Hz, 2 H, 5-
H, 7-H), 2.96 (s, 4 H, 2-H, 3-H), 2.87 (d, JH,H = 14 Hz, 2 H, 5-
2
H, 7-H), 2.36 (br. s, 2 H, 1-H, 4-H), 1.25 (s, 3 H, 8-H) ppm.
{1H}13C NMR (50.32 MHz, CDCl3, 25 °C): δ = 167.04 (1 C, C-9),
148.90 (1 C, C-11), 136.64 (1 C, C-13), 121.31 (1 C, C-14), 120.49
(1 C, C-12), 60.20 (2 C, C-2, C-3), 52.58 (2 C, C-5,C-7), 47.47 (1
C, C-6), 24.93 (1 C, C-8) ppm. HRMS (ESI): calcd. for C11H17N3
[M + H]+ 192.1495; found 192.1490.
6-Methyl-6-(pyridin-2-yl)-1,4-bis[(pyridin-2-yl)methyl]-1,4-diazepane
(4a): Solid K2CO3 (59.04 mmol, 8.16 g) and 2-picolyl chloride hy-
drochloride (11.81 mmol, 1.94 g) were added to a solution of 3
(5.91 mmol, 1.13 g) in MeCN (70 mL, no care was taken to exclude
moisture from the solvent.) The resulting suspension was stirred at
55 °C for 3 d. and was then allowed to cool to room temperature.
The solvent was removed with a rotary evaporator, and the residue
dissolved in toluene (30 mL). Crude 4a was obtained as an orange
oil after washing the toluene phase with water and the subsequent
removal of the solvent under reduced pressure. Trituration of the
crude product with hexane and removal of the solvent with a rotary
[Fe(4a)Cl](PF6) (6): A solution of FeCl2 (0.42 mmol, 0.05 g) in
MeOH (2 mL) was added to a solution of 4a (0.44 mmol, 0.17 g)
in MeOH (2 mL), and the mixture was stirred for 1 h at room tem-
perature. The addition of solid (nBu4N)PF6 produced a yellow pre-
cipitate, which was removed by filtration and washed with Et2O.
Isothermal diffusion of Et2O into a solution of the yellow solid in
MeCN generated crystals of 6. The crystals were washed with Et2O
and dried in vacuo to give a product with the correct elemental
analysis; yield 0.22 g (84%). C23H27ClF6FeN5P (609.76): calcd. C
Eur. J. Inorg. Chem. 2013, 958–967
965
© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim